Nice @Endpts piece from @JohnCendpts on the coming “vaccine war” for the almost $6billion annual market for pneumococcal vaccines that belongs, today, to $PFE’s Prevnar 13: https://t.co/cKP8Z3Ier2

Explains nicely why @Medicxi invested early in Sutrovax (now Vaxcyte $PCVX)